Skip to content
10-Q

Quarterly Report

REGENEREX PHARMA, INC. RGPX

0001472375-24-000074

← back to feed
Filed
Aug 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Aug 7, 2024 278.26M sh
Current Liabilities Q1 2024 · Jun 30, 2024 $4.41M
Current Liabilities Q1 2024 · Mar 31, 2024 $3.84M
Total Liabilities Q1 2024 · Jun 30, 2024 $5.04M
Total Liabilities Q1 2024 · Mar 31, 2024 $4.83M
Current Assets Q1 2024 · Jun 30, 2024 $2.36K
Current Assets Q1 2024 · Mar 31, 2024 $2.91K
Total Assets Q1 2024 · Jun 30, 2024 $729.09K
Total Assets Q1 2024 · Mar 31, 2024 $766.68K
Long Term Debt Q1 2024 · Mar 31, 2024 $184.23K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $372
Operating Cash Flow Q1 2024 · Jun 30, 2023 −$121.24K
Stockholders Equity Q1 2024 · Jun 30, 2023 −$1.08M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$1.12M
Net Income Q1 2024 · Jun 30, 2023 −$185.58K
Operating Income Q1 2024 · Jun 30, 2023 −$160.17K